Giovanni Corso

Scopus Publications

Frequency of bilateral prophylactic and contra-lateral risk-reducing mastectomies in women with germline PALB2 variants
Giovanni Corso, Carlo La Vecchia, Andrea Polizzi, Francesca Magnoni, Giuliarianna Abruzzese, Susanna Di Silvestre, Filippo Pesapane, Luca Nicosia, Giorgio Bogani, Mattia Intra, Paolo Veronesi, Viviana Galimberti
Familial Cancer, 2026
Invasive lobular and ductal breast cancers: a systematic review and metanalysis in association with BRCA1/2 mutation status
Giovanni Corso, Chiara Andreon, Carlo La Vecchia, Elisa Ileana Bottazzoli, Giuliarianna Abruzzese, Karin Favilla, Olivia Citterio, Elena Spoldi, Susanna Di Silvestre, Alessandra Margherita De Scalzi, Andrea Polizzi, Eleonora Meduri, Dario Trapani, Luca Nicosia, Filippo Pesapane, Daniela Bossi, Edi Brogi, Sherry Shen, Rita Mukhtar, Carmen Criscitiello, Paolo Veronesi, Sara Gandini, Francesca Magnoni, Giuseppe Curigliano
European Journal of Cancer, 2026
Cancer mortality in Europe in 2020, and an overview of trends since 1990
Claudia Santucci, Paola Bertuccio, Silvia Mignozzi, Margherita Pizzato, Giovanni Corso, Anna Odone, Eva Negri, Carlo La Vecchia, Gianfranco Alicandro
European Journal of Cancer Prevention, 2026
Introduction Cancer remains a leading cause of death in Europe, with over 1.2 million deaths recorded in the EU-27 in 2020. Methods Using WHO death certification data for 33 European countries from 1990 to 2020, we analyzed mortality trends for all neoplasms and 24 cancer sites, stratified by sex and age. We computed age-standardized mortality rates (ASMR) and applied joinpoint regression models to evaluate temporal trends. Results In 2020, the leading causes of cancer death in the EU-27 were lung (ASMR: 30.1/100 000), colorectal (14.6/100 000), and prostate (9.8/100 000) cancer in males and breast (13.8/100 000), lung (13.2/100 000), and colorectal (8.6/100 000) cancer in females. Pancreatic cancer was the fourth most common cause of cancer death in both sexes (ASMR: 8.2/100 000 males and 5.8/100 000 females). Most Central and Eastern European countries reported rates over two-fold higher compared to Western Europe. While overall cancer mortality declined since 1990 (average annual percent change: −1.3% in males and −0.8% in females in the EU-27), mortality from pancreatic (+0.2% in males and +0.8% in females) and female lung cancer (+1.9%) increased. Conclusion Declines in cancer mortality are attributable to reduced tobacco use, and improvements in organized screening programs and treatment. Pancreatic cancer mortality remains stable, while female lung cancer mortality continues to rise in some countries, largely due to later adoption of smoking and low cessation rates. Lower participation in screening programs and limited access to novel therapies in many Central and Eastern European countries contribute to poorer cancer outcomes, highlighting the need for equitable prevention, early detection, and treatment strategies across Europe.
Long-term oncological outcomes of robotic mastectomy for breast cancer: a randomized clinical trial
Antonio Toesca, Francesca Magnoni, Claudia Sangalli, Patrick Maisonneuve, Alessandra Gottardi, Alessandra Margherita De Scalzi, Elisa Ileana Bottazzoli, Andrea Polizzi, Nickolas Peradze, Daniele Presti, Alberto Concardi, Nicola Fusco, Francesca De Lorenzi, Giovanni Corso, Viviana Galimberti, Paolo Veronesi
British Journal of Surgery, 2026
Expectant management or conization for persistent low-grade cervical intraepithelial neoplasia: Analysis of 5-year outcomes
Giorgio Bogani, Francesco Sopracordevole, Giovanni Corso, Enrico Vizza, Paolo Scollo, Andrea Giannini, Violante Di Donato, Andrea Ciavattini, Rosa De Vincenzo, Barbara Gardella, Flavia Sorbi, Massimiliano Fambrini, Fabio Ghezzi, Jvan Casarin, Marco Petrillo, Caterina Borso, Noemi Tonti, Valentina Chiappa, Francesco Raspagliesi, Giuseppe Vizzielli
Tumori, 2026
Objective: To investigate to describe outcomes of conization or expectant management for women with persistent (>24 months) low-grade cervical intra-epithelial neoplasia. Methods: This is a retrospective analysis focusing on five-year outcomes after persistent, histologically confirmed, low-grade cervical intra-epithelial neoplasia undergoing conization or expectant management. Results: Charts of 219 women with persistent low-grade cervical lesions were retrieved. Overall, 98 (44.7%) and 121 (55.3%) women had conization and observation, respectively. Patients receiving conization were older than patients having observation (43 (range, 24-77) vs. 39 (range, 25-68) years; p=0.013). Focusing on the group of patients receiving conization, 16 (16.3%) women were diagnosed with CIN2+. The five-year risk of secondary conization was 5% (n=5). Focusing on patients having observation (n=121), 18 (14.8%) patients received conization, after a median of 16.5 (range, 6-30) months. Seven (5.8%) and 11 (9.1%) patients were diagnosed with persistent CIN1 and CIN2+, respectively. Not fully visible squamous-columnar junction at colposcopic examination (p=0.035) was associated with CIN2+ occurrence. No invasive cancer was observed Conclusions: Conization for persistent low-grade cervical intra-epithelial neoplasia revealed “occult” CIN2+ in 16% of patients. However, expectant management appears safe and effective in this context, in women with fully visible squamous columnar junction. The decision between conization and expectant management should be discussed on an individual basis.
Cancer mortality predictions for 2025 in Latin America with focus on prostate cancer
Silvia Mignozzi, Claudia Santucci, Fabio Levi, Matteo Malvezzi, Paolo Boffetta, Giovanni Corso, Eva Negri, Carlo La Vecchia
European Journal of Cancer Prevention, 2026
We provided cancer mortality rate estimates for the year 2025 in six Latin American countries (Argentina, Brazil, Chile, Colombia, Cuba, and Mexico), focusing on prostate cancer. We extracted mortality data for all cancers combined and the most common sites from the WHO and population data since 1970 from the United Nations. Estimates for 2025 were computed applying a linear regression to the most recent segment identified through Poisson join-point regression. Avoided deaths number from 1991 to 2025 was estimated by applying the 1990 peak rate to population data. Mortality from all cancers is predicted to be favorable for both sexes in all countries. The lowest total cancer mortality rates are expected in Mexico (67.7/100 000 males; 61.4/100 000 females), while the highest ones in Cuba (136.6/100 000 males; 91.6/100 000 females). Prostate cancer mortality is declining in all countries, although rates remain high in Cuba (25.2/100 000 in 2025). Downward patterns are observed for all age groups in all countries, except the elderly in Cuba and Mexico. Declines in mortality are predicted for colorectal (except for males in Brazil and Cuba, and females in Chile), stomach (except Cuban males), pancreatic (except Argentinian and Cuban males), lung, bladder (except Argentinian females), breast, and ovarian (except Cuba) cancers. Uterine cancer mortality, particularly from cervical cancer, remains highin Argentina (10.2/100 000) and Cuba (10.4/100 000). Except for uterine, stomach, and prostate cancers, cancer mortality rates are still relatively low in Latin America, except Cuba. Controlling tobacco particularly in Cuba, implementing organized cervical cancer screening, and advancing cancer treatment also for prostate cancer remain crucial in all countries considered.
The Algal Antioxidant Carotenoid Diatoxanthin as a Modulator of Inflammation and Angiogenesis in Triple-Negative Breast Cancer Cells
Danilo Morelli, Luana Calabrone, Luisa Di Paola, Giovanna Chiorino, Paola Ostano, Douglas M. Noonan, Giovanni Corso, Adriana Albini
Antioxidants, 2026
Algal carotenoids play a promising role in handling chronic diseases due to their diverse bioactive properties, including anti-inflammatory, antioxidant, and anticancer effects. This study assesses the activity of the antioxidant xanthophyll diatoxanthin (Dt), derived from marine diatoms, against triple-negative breast cancer (TNBC) cells using in vitro models, gene expression evaluation, and explores its role in potentiating the cytotoxic effect of chemotherapy. Dt exhibited selective activity against MDA-MB-231 and BT-549 TNBC cells at concentrations ≥12.5 ng/mL, with maximal effects observed at 25 ng/mL while sparing human umbilical vein endothelial cells (HUVECs) at these doses. When combined with doxorubicin (0.1–0.5 μM), Dt enhanced the anti-tumor efficacy in both TNBC cell lines, further reducing cell viability compared with doxorubicin alone (p < 0.05–0.001). Dt also exerted its activity in inhibiting migration and chemotaxis by approximately 30–50% compared with the controls (p < 0.01) and suppressing 3D-tumor spheroid growth at day 12 (up to >50% reduction, p < 0.001). Notably, secretome analysis revealed Dt-induced changes in inflammatory, oxidative and angiogenic mediators, highlighting its ability to modulate the TNBC microenvironment. Dt also downregulated key pro-survival, pro-angiogenic and pro-tumorigenic genes in both TNBC cell lines, supporting its role in disrupting oncogenic pathways. Angiogenesis-related genes were significantly reduced. Dt also decreased the expression of angiogenic mediators in HUVECs, supporting Dt’s role in inhibiting tumor vascularization. Results on gene expression regulation were also confirmed by RNA-Seq analysis. These findings pose Dt as a promising chemopreventing candidate in the challenging fight against TNBC, a well-known type of cancer that is aggressive and resistant to conventional therapies, targeting critical pathways for tumor survival, such as inflammation, angiogenesis, tumor cell growth, and cell migration. Given its selective activity against TNBC cells, ability to enhance chemotherapy efficacy, and modulation of the tumor microenvironment, Dt holds promise as a complementary drug for cancer prevention and interception. Future studies should focus on validating these effects in vivo and exploring Dt’s potential in combinatorial treatment strategies for cancer.
Cancer as a main contributor to multimorbidity in the UK Biobank: analysis of risk factors using conventional statistical modelling and machine learning
Linia Patel, Silvia Mignozzi, Margherita Pizzato, Giovanni Corso, Carlo La Vecchia, Gianfranco Alicandro
European Journal of Cancer Prevention, 2026
Cancer frequently co-occurs with other chronic conditions, contributing substantially to disease burden. Multimorbidity is an increasing public health concern, resulting from complex interactions between sociodemographic, lifestyle, and environmental factors. The study aimed to identify the main predictors of multimorbidity using both conventional statistical models and machine learning approaches. We analysed data from 138 126 UK Biobank participants aged 39–73 years. Twenty potential risk factors were assessed using Fine and Gray competing risk regression and random survival forests (RSF). Over the five-year follow-up period, 4384 individuals developed multimorbidity, with cancer present in 52.3% of cases. Five-year cumulative incidence was 3.9% in males and 2.6% in females. Increased waist circumference [males – hazard ratio: 1.15, 95% confidence interval (CI): 1.00–1.31; females – hazard ratio: 1.29, 95% CI: 1.09–1.54] and smoking (per 5 pack-years: males – hazard ratio: 1.06, 95% CI: 1.05–1.07; females – hazard ratio: 1.08, 95% CI: 1.06–1.10) significantly increased risk. Both insufficient and prolonged sleep were linked to a higher risk, especially among females (hazard ratio for prolonged sleep: 1.68, 95% CI: 1.17–2.40). Compared with moderate drinkers, former drinkers, lifelong abstainers, and heavy drinkers showed elevated risks. RSF found smoking, waist circumference, and sleep duration as key predictors in men, while alcohol use, smoking, and waist circumference were most important in women. Available dietary information, physical activity, and air pollution were not major predictors. Smoking, obesity, alcohol, and sleep duration are key risk factors to target in midlife to reduce the future burden of multimorbidity.
Cancer mortality predictions for 2026 in selected Asian countries and Australia with focus on prostate cancer
Claudia Santucci, Silvia Mignozzi, Fabio Levi, Matteo Malvezzi, Giovanni Corso, Eva Negri, Giorgio Gandaglia, Carlo La Vecchia
European Journal of Cancer Prevention, 2026
Introduction We estimated cancer mortality figures for 2026 in five major Asian countries and Australia, with a specific focus on prostate cancer. Methods We computed country- and sex-specific annual age-standardized mortality rates (ASRs) for all cancers combined and for the 10 most common cancer sites, using data from the WHO and the United Nations Population Division up to 2022 or the most recent available year. We predicted figures for 2026 and estimated the number of avoided cancer deaths in 1994–2026. Results Predicted mortality rates for all cancers combined in 2026 are favourable across all considered countries and in both sexes, with the largest declines expected in the Republic of Korea (−20.5% in males and −10.2% in females compared with 2020–2022). In 2026, the lowest predicted male rate is expected in the Philippines (72.1 per 100 000), and the highest one in Australia (92.3 per 100 000). Among females, the lowest predicted ASR (42.2 per 100 000) is in the Republic of Korea, whereas the highest one (74.1 per 100 000) in the Philippines. Trends are generally favourable for lung, stomach, colorectum, and other major neoplasms considered, except pancreas. Predicted prostate cancer mortality is favourable in all countries and across all age groups. Rates are expected to remain low in Hong Kong SAR, Japan, and the Republic of Korea, with ASRs below 4 per 100 000 males. Since the 1993 observed peak rate, an estimated 132 000 total cancer deaths were avoided in Hong Kong SAR, 75 000 in Israel, 1 366 000 in Japan, 720 000 in the Republic of Korea, 328 000 in Australia, and 102 000 among men in the Philippines. Conclusions Declining cancer mortality is predicted in the countries considered. These trends largely reflect smoking cessation along with improvements in prevention, early detection, and treatment. However, substantial geographic disparities persist, highlighting the need for strengthened cancer control strategies, particularly in ageing populations.
Microcalcifications matter: Diagnostic and biological differences in DCIS
Luca Nicosia, Luciano Mariano, Carmen Mallardi, Filippo Pesapane, Lorenza Meneghetti, Francesca Abbate, Samuele Frassoni, Vincenzo Bagnardi, Cristian Gialain, Giovanni Corso, Nicola Fusco, Enrico Cassano
Cancer Treatment and Research Communications, 2026
INTRODUCTION: Ductal carcinoma in situ (DCIS) is a non-invasive breast cancer increasingly detected through screening. While microcalcifications are the most common feature, a subset lacks them, posing diagnostic and management challenges. We investigated the relationship between radiological presentation (calcified vs. non-calcified) and the risk of upstaging to invasive carcinoma. MATERIALS AND METHODS: We retrospectively analyzed 196 patients with biopsy-proven DCIS who underwent surgery between 2000 and 2023. Ninety-eight (98) non-calcified cases diagnosed via ultrasound-guided vacuum-assisted biopsy were matched with 98 calcified cases diagnosed via stereotactic vacuum-assisted biopsy, based on age, grade, and macroscopic removal. We investigated the associations between upstaging and potential predictors, including calcification status, age at biopsy, lesion size, and histologic grade at biopsy. RESULTS: The overall underestimation rate was 13.8% (27/196). Non-calcified DCIS showed a higher upstaging rate than calcified DCIS (19% vs. 8%; multivariable OR for calcified DCIS: 0.31, 95% CI: 0.12-0.78, p = 0.013). Larger lesions increased the risk of underestimation (OR per 5 mm: 1.21, 95% CI: 1.06-1.38, p = 0.005), while age was not significant (OR per 5 years: 1.01, p = 0.91). CONCLUSIONS: Non-calcified DCIS and larger lesion size seemed independently associated with upstaging to invasive carcinoma, highlighting the clinical relevance of radiological presentation for risk stratification.
Artificial intelligence for risk-stratified breast cancer screening: a systematic review of evidence, clinical integration, and ethical implications in risk assessment tools
Filippo Pesapane, Francesca Caumo, Paola Mantellini, Giovanni Irmici, Catherine Depretto, Silvia Penco, Anna Rotili, Chiara Trentin, Valeria Dominelli, Giovanni Corso, Francesca Magnoni, Matteo Lazzeroni, Sonia Santicchia, Gianfranco Paride Scaperrotta, Enrico Cassano
Radiologia Medica, 2026
Inflammation and cancer cell survival: TRAF2 as a key player
Adriana Albini, Luisa Di Paola, Giampiero Mei, Denisa Baci, Nicola Fusco, Giovanni Corso, Douglas Noonan
Cell Death and Disease, 2025
Sleep duration, selected circulating biomarkers, and colorectal cancer risk
Marta Rossi, Alessia Pauletto, Silvia Mignozzi, Paola Bertuccio, Konstantinos K Tsilidis, Massimiliano Mutignani, Marcello Cintolo, Irene Cottone, Roberto Penagini, Maurizio Vecchi, Michail Katsoulis, Simone Rampelli, Federica D’Amico, Giovanni Corso, Mirko Marino, Marco Rendine, Cristian Del Bo’, Patrizia Riso, Rossella Bonzi, Simone Guglielmetti, Carlo La Vecchia, Francesca Bravi
European Journal of Cancer Prevention, 2025
Invasive lobular carcinoma: Strategies and perspectives from the lobular breast cancer research group
Giovanni Corso, Sherry Shen, Carmen Criscitiello, Rita Mukhtar, Lauren Gamble, Elena Guerini Rocco, Filippo Pesapane, Luca Nicosia, Komal Jhaveri, Beatrice Taurelli Salimbeni, Giulia Massari, Eleonora Meduri, Alessandra Margherita De Scalzi, Alberto Concardi, Francesca Magnoni, Anita Mamtani, Fresia Pareja, Maria Cristina Leonardi, Virgilio Sacchini, Giorgio Bogani, Carlo La Vecchia, Daniele Presti, Marco Angelo Colleoni, Paolo Veronesi, Mark E. Robson
Cancer Treatment Reviews, 2025
Cancer prevention and interception with antidiabetic and anti-obesity drugs: Current and future perspectives
Adriana Albini, Anna Rita Cantelmo, Lorenzo Mortara, Douglas M. Noonan, Giovanni Corso
Seminars in Cancer Biology, 2025
From Combination Early Detection to Multicancer Testing: Shifting Cancer Care toward Proactive Prevention and Interception
Adriana Albini, Dario Trapani, Francesco Bertolini, Douglas M. Noonan, Roberto Orecchia, Giovanni Corso
Cancer Prevention Research, 2025
Diverging trends in lung cancer: a 26-year analysis of sex-specific patterns and histological shifts in Northern Italy
Luca Bertolaccini, Claudia Santucci, Carlo La Vecchia, Federica Toffolutti, Giovanni Corso, Lorenzo Spaggiari, Diego Serraino
European Journal of Cancer Prevention, 2025
Second-hit CDH1 gene mechanisms in hereditary diffuse gastric and lobular breast cancer syndrome: frequency and impact on tumorigenesis
Giovanni Corso, Francesca Magnoni, Matteo Dal Molin, Elena Marino, Luca Nicosia, Filippo Pesapane, Douglas M Noonan, Adriana Albini
Human Molecular Genetics, 2025
Positive Margin Rates After Breast-Conserving Surgery by Histologic Subtype: A Systematic Review and Meta-analysis Evaluating the Impact of Oncoplastic Surgery
Kayla M. Switalla, Israel O. Falade, Astrid Quirarte, Molly Baxter, Mandeep Kaur, Rita A. Sakr, Giovanni Corso, Rita A. Mukhtar
Annals of Surgical Oncology, 2025
Raising the bar: Evaluating quality and consistency in clinical guidelines for surgical management of pulmonary carcinoid
Luca Bertolaccini, Claudia Bardoni, Giovanni Caffarena, Matteo Chiari, Cristina Diotti, Antonio Mazzella, Lavinia Benini, Francesca Spada, Giovanni Corso, Eleonora Pisa, Monica Casiraghi, Nicola Fazio, Lorenzo Spaggiari
European Journal of Cancer Prevention, 2025
Preliminary Evaluation of Radiomics in Contrast-Enhanced Mammography for Prognostic Prediction of Breast Cancer
Luca Nicosia, Luciano Mariano, Aurora Gaeta, Sara Raimondi, Filippo Pesapane, Giovanni Corso, Paolo De Marco, Daniela Origgi, Claudia Sangalli, Nadia Bianco, Serena Carriero, Sonia Santicchia, Enrico Cassano
Cancers, 2025
Invasive Pleomorphic Lobular Carcinoma of the breast: Clinicopathological features, treatment patterns and outcomes
N Peradze, A Polizzi, E Pagan, E Bottazzoli, V Bagnardi, C Sangalli, C Morigi, E De Camili, P Rafaniello Raviele, G Corso, V Galimberti, M Colleoni, P Veronesi
European Journal of Surgical Oncology, 2025
Endometriosis and cancer risk
Giorgio Bogani, Valentina Chiappa, Francesco Raspagliesi, Giovanni Corso
European Journal of Cancer Prevention, 2025
Hereditary diffuse gastric and lobular breast cancer syndrome associated with germline CDH1 variants: focus on lobular breast cancer
Giovanni Corso, Francesca Magnoni, Giorgio Bogani, Paolo Veronesi, Viviana Galimberti, Adriana Albini
Journal of Cancer Research and Clinical Oncology, 2025
Malignant germ cells tumor of the ovary
Francesca De Maria, Frédéric Amant, Valentina Chiappa, Biagio Paolini, Alice Bergamini, Robert Fruscio, Giovanni Corso, Francesco Raspagliesi, Giorgio Bogani
Journal of Gynecologic Oncology, 2025
Human papillomavirus vaccination coverage in Italy
Giorgio Bogani, Giovanni Scambia, Francesco Raspagliesi, Giovanni Corso
European Journal of Cancer Prevention, 2025
The global burden of kidney cancer: trends in mortality and incidence with predictions to 2025
Silvia Mignozzi, Claudia Santucci, Alberto Briganti, Francesco Montorsi, Carlo La Vecchia, Giovanni Corso, Eva Negri, Giorgio Gandaglia
European Journal of Cancer Prevention, 2025
Physical activity and exercise health benefits: Cancer prevention, interception, and survival
Adriana Albini, Carlo La Vecchia, Francesca Magnoni, Ornella Garrone, Danilo Morelli, Jaak Ph. Janssens, Alain Maskens, Gad Rennert, Viviana Galimberti, Giovanni Corso
European Journal of Cancer Prevention, 2025
Adjuvant VaccInation After Conization for the Treatment for CervicAL Dysplasia
Carlotta Caia, Francesca De Maria, Francesco Sopracordevole, Andrea Ciavattini, Jvan Casarin, Fabio Ghezzi, Giuseppe Vizzielli, Valentina Chiappa, Umberto Leone Roberti Maggiore, Camilla Valsecchi, Giovanni Scambia, Francesco Raspagliesi, Giovanni Corso, Giorgio Bogani
European Journal of Cancer Prevention, 2025
Trends in diffuse type of gastric cancer: Focus on younger women
Giovanni Corso, Claudia Santucci, Federica Toffolutti, Eleonora Pisa, Carlo La Vecchia, Diego Serraino
European Journal of Cancer Prevention, 2024
Non-contrast MRI and post-mastectomy silicone breast implant rupture: Preventing false positive diagnoses
Luca Mazzocconi, Francesca De Lorenzi, Riccardo Carbonaro, Valerio Lorenzano, Anna Rotili, Filippo Pesapane, Giulia Signorelli, Pietro Caldarella, Giovanni Corso, Enrico Cassano, Paolo Veronesi
European Journal of Cancer Prevention, 2024
Long-term outcome of invasive pure micropapillary breast cancer compared with invasive mixed micropapillary and invasive ductal breast cancer: a matched retrospective study
Francesca Magnoni, Beatrice Bianchi, Eleonora Pagan, Giovanni Corso, Isabella Sala, Vincenzo Bagnardi, Sangalli Claudia, Roberta Brancaccio, Elisa Bottazzoli, Antony Boato, Elisabetta Munzone, Silvia Dellapasqua, Nicola Fusco, Galimberti Viviana, Paolo Veronesi
Breast Cancer Research and Treatment, 2024
The global gastric cancer consortium: an update from the Stomach cancer Pooling (StoP) project
Claudio Pelucchi, Carlo La Vecchia, Rossella Bonzi, Eva Negri, Giovanni Corso, Stefania Boccia, Paolo Boffetta, M. Constanza Camargo, Maria Paula Curado, Nuno Lunet, Jesus Vioque, Zuo-Feng Zhang, and
European Journal of Cancer Prevention, 2024
The Past and Future of Angiogenesis as a Target for Cancer Therapy and Prevention
Adriana Albini, Douglas M. Noonan, Paola Corradino, Francesca Magnoni, Giovanni Corso
Cancer Prevention Research, 2024
Invasive lobular breast cancer: Focus on prevention, genetics, diagnosis, and treatment
Giovanni Corso, Nicola Fusco, Elena Guerini-Rocco, Maria Cristina Leonardi, Carmen Criscitiello, Paola Zagami, Eleonora Nicolò, Giovanni Mazzarol, Carlo La Vecchia, Filippo Pesapane, Cristina Zanzottera, Paolo Tarantino, Salvatore Petitto, Beatrice Bianchi, Giulia Massari, Anthony Boato, Andrea Sibilio, Andrea Polizzi, Giuseppe Curigliano, Alessandra Margherita De Scalzi, Federica Lauria, Bernardo Bonanni, Monica Marabelli, Anna Rotili, Luca Nicosia, Adriana Albini, Mariarosaria Calvello, Rita A. Mukhtar, Mark E. Robson, Virgilio Sacchini, Gad Rennert, Viviana Galimberti, Paolo Veronesi, Francesca Magnoni
Seminars in Oncology, 2024
Points to consider regarding prophylactic total gastrectomy in germline CDH1 variant carriers
Giovanni Corso, Jeremy L. Davis, Vivian E. Strong
Journal of Surgical Oncology, 2024
The multicenter experience in the multidisciplinary Italian breast units: A review and update
Francesca Magnoni, Corrado Tinterri, Giovanni Corso, Giuseppe Curigliano, Maria Cristina Leonardi, Antonio Toesca, Nicola Rocco, Francesca Catalano, Beatrice Bianchi, Federica Lauria, Pietro Caldarella, Gianmatteo Pagani, Viviana Galimberti, Paolo Veronesi
European Journal of Cancer Prevention, 2024
Comparison of long-term outcome between clinically high risk lobular versus ductal breast cancer: a propensity score matched study
Francesca Magnoni, Giovanni Corso, Patrick Maisonneuve, Beatrice Bianchi, Giuseppe Accardo, Claudia Sangalli, Giulia Massari, Anna Rotili, Luca Nicosia, Filippo Pesapane, Emilia Montagna, Giovanni Mazzarol, Viviana Galimberti, Paolo Veronesi, Giuseppe Curigliano
Eclinicalmedicine, 2024
Tools to Guide Radiation Oncologists in the Management of DCIS
Maria Cristina Leonardi, Maria Alessia Zerella, Matteo Lazzeroni, Nicola Fusco, Paolo Veronesi, Viviana Enrica Galimberti, Giovanni Corso, Samantha Dicuonzo, Damaris Patricia Rojas, Anna Morra, Marianna Alessandra Gerardi, Chiara Lorubbio, Mattia Zaffaroni, Maria Giulia Vincini, Roberto Orecchia, Barbara Alicja Jereczek-Fossa, Francesca Magnoni
Healthcare Switzerland, 2024
CDH1 Genotype Exploration in Women With Hereditary Lobular Breast Cancer Phenotype
Giovanni Corso, Elena Marino, Cristina Zanzottera, Carla Oliveira, Loris Bernard, Debora Macis, Joana Figueiredo, Joana Pereira, Patrícia Carneiro, Giulia Massari, Massimo Barberis, Alessandra Margherita De Scalzi, Sergio Vincenzo Taormina, Elham Sajjadi, Claudia Sangalli, Sara Gandini, Oriana D’Ecclesiis, Cristina Maria Trovato, Anna Rotili, Filippo Pesapane, Luca Nicosia, Carlo La Vecchia, Viviana Galimberti, Elena Guerini-Rocco, Bernardo Bonanni, Paolo Veronesi
JAMA Network Open, 2024
Disparities in Breast Cancer Diagnostics: How Radiologists Can Level the Inequalities
Filippo Pesapane, Priyan Tantrige, Anna Rotili, Luca Nicosia, Silvia Penco, Anna Carla Bozzini, Sara Raimondi, Giovanni Corso, Roberto Grasso, Gabriella Pravettoni, Sara Gandini, Enrico Cassano
Cancers, 2024
Contrast-Enhanced Mammography (CEM) compared to Breast Magnetic Resonance (MRI) in the evaluation of breast lobular neoplasia
Luca Nicosia, Anna Rotili, Filippo Pesapane, Anna Carla Bozzini, Ottavia Battaglia, Giuseppe Pellegrino, Nicola Fusco, Francesca Maria Porta, Samuele Frassoni, Vincenzo Bagnardi, Giovanni Corso, Claudia Sangalli, Enrico Cassano
Breast Cancer Research and Treatment, 2024
Exploring non-surgical alternatives for low to intermediate-grade in situ ductal carcinoma of the breast using vacuum-assisted excision: the VACIS protocol
Luca Nicosia, Luciano Mariano, Antuono Latronico, Anna Carla Bozzini, Federica Bellerba, Aurora Gaeta, Filippo Pesapane, Giovanni Mazzarol, Nicola Fusco, Giovanni Corso, Claudia Sangalli, Cristian Gialain, Matteo Lazzeroni, Sara Raimondi, Enrico Cassano
Frontiers in Medicine, 2024
Germline CDH1 variants in hereditary diffuse gastric cancer syndrome with focus on younger women
Giovanni Corso, Giovanni Comelli, Paolo Veronesi, Beatrice Bianchi, Salvatore Petitto, Andrea Polizzi, Antonia Girardi, Antonio Cioffi, Carlo La Vecchia, Vincenzo Bagnardi, Francesca Magnoni
Journal of Cancer Research and Clinical Oncology, 2023
A Pictorial Exploration of Mammary Paget Disease: Insights and Perspectives
Luciano Mariano, Luca Nicosia, Davide Pupo, Antonia Maria Olivieri, Sofia Scolari, Filippo Pesapane, Antuono Latronico, Anna Carla Bozzini, Nicola Fusco, Marta Cruz Blanco, Giovanni Mazzarol, Giovanni Corso, Viviana Enrica Galimberti, Massimo Venturini, Maria Pizzamiglio, Enrico Cassano
Cancers, 2023
Germline pathogenic variants in metaplastic breast cancer patients and the emerging role of the BRCA1 gene
Giovanni Corso, Monica Marabelli, Mariarosaria Calvello, Sara Gandini, Matilde Risti, Irene Feroce, Sara Mannucci, Antonia Girardi, Alessandra Margherita De Scalzi, Francesca Magnoni, Elena Marino, Loris Bernard, Paolo Veronesi, Elena Guerini-Rocco, Massimo Barberis, Aliana Guerrieri-Gonzaga, Bernardo Bonanni
European Journal of Human Genetics, 2023
Clinical Implication of CDH1 Mutations in Genetic Testing for Diffuse Gastric Cancer Patients
Giovanni Corso, Cristina Maria Trovato, Salvatore Petitto, Antonia Girardi, Alessandra Margherita De Scalzi, Beatrice Bianchi, Francesca Magnoni, Antonio Cioffi, Viviana Galimberti, Paolo Veronesi, Giovanni Mazzarol, Patrick Maisonneuve
Oncology Switzerland, 2023
Future Directions in the Assessment of Axillary Lymph Nodes in Patients with Breast Cancer
Filippo Pesapane, Luciano Mariano, Francesca Magnoni, Anna Rotili, Davide Pupo, Luca Nicosia, Anna Carla Bozzini, Silvia Penco, Antuono Latronico, Maria Pizzamiglio, Giovanni Corso, Enrico Cassano
Medicina Lithuania, 2023
Hereditary gastric and breast cancer syndromes with lung metastasis: narrative review of molecular and clinical insights
Mariia Ivanova, Jessica Evangelista, Konstantinos Venetis, Elham Sajjadi, Filippo Lococo, Giovanni Corso, Michele Ghidini, Nicola Fusco
Ame Surgical Journal, 2023
Metaplastic breast cancer: An all-round multidisciplinary consensus
Giovanni Corso, Carmen Criscitiello, Luca Nicosia, Filippo Pesapane, Elisa Vicini, Francesca Magnoni, Andrea Sibilio, Cristina Zanzottera, Alessandra Margherita De Scalzi, Sara Mannucci, Monica Marabelli, Mariarosaria Calvello, Irene Feroce, Paola Zagami, Francesca Maria Porta, Antonio Toesca, Paolo Tarantino, Eleonora Nicolò, Giovanni Mazzarol, Carlo La Vecchia, Bernardo Bonanni, Maria Cristina Leonardi, Paolo Veronesi, Nicola Fusco
European Journal of Cancer Prevention, 2023
Cancer prevention: Innovative strategies in the role of the European Cancer Prevention Organization
Giovanni Corso, Jaak Ph. Janssens, Carlo La Vecchia
European Journal of Cancer Prevention, 2023
FDG and Non-FDG Radiopharmaceuticals for PET Imaging in Invasive Lobular Breast Carcinoma
Laura Gilardi, Lighea Simona Airò Farulla, Giuseppe Curigliano, Giovanni Corso, Maria Cristina Leonardi, Francesco Ceci
Biomedicines, 2023
Risk and incidence of breast cancer in transgender individuals: A systematic review and meta-analysis
Giovanni Corso, Sara Gandini, Oriana D’Ecclesiis, Manuelita Mazza, Francesca Magnoni, Paolo Veronesi, Viviana Galimberti, Carlo La Vecchia
European Journal of Cancer Prevention, 2023
Ductal Carcinoma In Situ (DCIS) and Microinvasive DCIS: Role of Surgery in Early Diagnosis of Breast Cancer
Francesca Magnoni, Beatrice Bianchi, Giovanni Corso, Erica Anna Alloggio, Susanna Di Silvestre, Giuliarianna Abruzzese, Virgilio Sacchini, Viviana Galimberti, Paolo Veronesi
Healthcare Switzerland, 2023
Breast Digital Tomosynthesis versus Contrast-Enhanced Mammography: Comparison of Diagnostic Application and Radiation Dose in a Screening Setting
Luca Nicosia, Anna Carla Bozzini, Filippo Pesapane, Anna Rotili, Irene Marinucci, Giulia Signorelli, Samuele Frassoni, Vincenzo Bagnardi, Daniela Origgi, Paolo De Marco, Ida Abiuso, Claudia Sangalli, Nicola Balestreri, Giovanni Corso, Enrico Cassano
Cancers, 2023
Hereditary Gastric Cancer: Single-Gene or Multigene Panel Testing? A Mono-Institutional Experience
Mariarosaria Calvello, Monica Marabelli, Sara Gandini, Elena Marino, Loris Bernard, Matteo Dal Molin, Giulia Di Cola, Cristina Zanzottera, Giovanni Corso, Nicola Fazio, Lorenzo Gervaso, Uberto Fumagalli Romario, Massimo Barberis, Aliana Guerrieri-Gonzaga, Lucio Bertario, Davide Serrano, Bernardo Bonanni
Genes, 2023
CDH1 mutations recurrence and global clustering in genetically tested families with hereditary diffuse gastric cancer syndrome: results from a systematic study
Giovanni Corso, Valentina Tagliaferri, Giulia Massari, Antonio Cioffi, Elisabetta Maria Cristina Rossi, Paolo Veronesi, Francesca Magnoni
Familial Cancer, 2023
Robot-assisted mastectomy: next major advance in breast cancer surgery
Antonio Toesca, Hyung Seok Park, Jai Min Ryu, Yeon Jin Kim, Jeea Lee, Claudia Sangalli, Patrick Maisonneuve, Emilia Marrazzo, Giada Pozzi, Guglielmo Gazzetta, Filippo Montemurro, Giovanni Corso, Germana Lissidini, Pietro Caldarella, Erica Mazzotta, Giulia Massari, Paolo Veronesi
British Journal of Surgery, 2023
A propensity score–matched analysis of breast-conserving surgery plus whole-breast irradiation versus mastectomy in breast cancer
Francesca Magnoni, Giovanni Corso, Patrick Maisonneuve, Giulia Massari, Luca Alberti, Giulia Castelnovo, Maria Cristina Leonardi, Virgilio Sacchini, Viviana Galimberti, Paolo Veronesi
Journal of Cancer Research and Clinical Oncology, 2023
“This house believes that: Sentinel node biopsy alone is better than TAD after NACT for cN+ patients”
Viviana Galimberti, Sabrina Kahler Ribeiro Fontana, Elisa Vicini, Consuelo Morigi, Manuela Sargenti, Giovanni Corso, Francesca Magnoni, Mattia Intra, Paolo Veronesi
Breast, 2023
Tribute to Raquel Seruca
Giovanni Corso
European Journal of Cancer Prevention, 2023
Hereditary Lobular Breast Cancer: A Newly Defined Syndrome
Vanessa Blair, Antonia Girardi, Giovanni Corso
Hereditary Gastric and Breast Cancer Syndrome Cdh1 One Genotype with Multiple Phenotypes, 2023
Worldwide CDH1 Germline Mutation Frequency
Giulia Massari, Valentina Tagliaferri, Giovanni Corso
Hereditary Gastric and Breast Cancer Syndrome Cdh1 One Genotype with Multiple Phenotypes, 2023
Hereditary Gastric and Breast Cancer Syndrome: CDH1: One Genotype with Multiple Phenotypes
Giovanni Corso, Paolo Veronesi, Franco Roviello
Hereditary Gastric and Breast Cancer Syndrome Cdh1 One Genotype with Multiple Phenotypes, 2023
Prophylactic Total Gastrectomy: How Many?
Francesco Ferrara, Giulia Massari, Valentina Tagliaferri, Giovanni Corso
Hereditary Gastric and Breast Cancer Syndrome Cdh1 One Genotype with Multiple Phenotypes, 2023
β-Hemoglobinopathies and Early Onset of Cancers in Adulthood: Epidemiology in Southeastern Asia and Brunei with Emphasis for Prevention and Treatment
Meric A. Altinoz, Francesca Magnoni, Aysel Ozpinar, Giovanni Corso
Hereditary Gastric and Breast Cancer Syndrome Cdh1 One Genotype with Multiple Phenotypes, 2023
Prevalence of Germline BRCA1/2 Variants in Ashkenazi and Non-Ashkenazi Prostate Cancer Populations: A Systematic Review and Meta-Analysis
Antonio Cioffi, Ottavio De Cobelli, Paolo Veronesi, Carlo La Vecchia, Patrick Maisonneuve, Giovanni Corso
Cancers, 2023
Prognostic impact of germline BRCA1/2 pathogenic variants in breast cancer
Giovanni Corso, Antonia Girardi, Mariarosaria Calvello, Sara Gandini, Aurora Gaeta, Monica Marabelli, Francesca Magnoni, Paolo Veronesi, Aliana Guerrieri-Gonzaga, Bernardo Bonanni
Breast Cancer Research and Treatment, 2023
Advances in breast cancer risk modeling: integrating clinics, imaging, pathology and artificial intelligence for personalized risk assessment
F. Pesapane, Ottavia Battaglia, Giuseppe Pellegrino, Elisa Mangione, Salvatore Petitto, Eliza Del Fiol Manna, Laura Cazzaniga, Luca Nicosia, Matteo Lazzeroni, Giovanni Corso, Nicola Fusco, Enrico Cassano
Future Oncology, 2023
ASO Author Reflections: Is Breast-Conserving Surgery a Safe Treatment Option for High-Risk Breast Cancer?
Francesca Magnoni, Giovanni Corso
Annals of Surgical Oncology, 2022
Points to Consider Regarding De-Escalation Surgery in High-Risk Breast Cancer
Giovanni Corso, Francesca Magnoni, Paolo Veronesi
Annals of Surgical Oncology, 2022
Progress in breast cancer surgical management
Francesca Magnoni, Giovanni Corso
European Journal of Cancer Prevention, 2022
Local treatment in patients with hereditary breast cancer: decision-making process in low-, moderate-, high-penetrance pathogenic germline mutation carriers
Andrea Sibilio, Annalisa Curcio, Antonio Toesca, Elisabetta Maria Cristina Rossi, Giovanni Corso
Current Opinion in Oncology, 2022
Progress in prostate cancer prevention
Gabriele Cozzi, Gennaro Musi, Matteo Ferro, Antonio Cioffi, Ottavio de Cobelli, Giovanni Corso
European Journal of Cancer Prevention, 2022
Surgical and Oncologic Outcomes of Robotic and Conventional Nipple-Sparing Mastectomy with Immediate Reconstruction: International Multicenter Pooled Data Analysis
Hyung Seok Park, Jeea Lee, Hung-Wen Lai, Jung Mi Park, Jai Min Ryu, Jeong Eon Lee, Jee Ye Kim, Emilia Marrazzo, Alessandra Margherita De Scalzi, Giovanni Corso, Filippo Montemurro, Guglielmo Gazzetta, Giada Pozzi, Antonio Toesca
Annals of Surgical Oncology, 2022
Microsatellite instability in gastrointestinal cancers
Giovanni Corso
European Journal of Human Genetics, 2022
Points to Consider Regarding Risk-Reducing Mastectomy in High-, Moderate-, and Low-Penetrance Gene Carriers
Giovanni Corso, Mark E. Robson, Virgilio Sacchini
Annals of Surgical Oncology, 2022
Metaplastic breast cancers and triple-negative breast cancers of no special type: Are they prognostically different? A systematic review and meta-analysis
Giovanni Corso, Oriana D’Ecclesiis, Francesca Magnoni, Erica Mazzotta, Fabio Conforti, Paolo Veronesi, Elham Sajjadi, Konstantinos Venetis, Nicola Fusco, Sara Gandini
European Journal of Cancer Prevention, 2022
Surgical Management of Inherited Breast Cancer: Role of Breast-Conserving Surgery
Francesca Magnoni, Virgilio Sacchini, Paolo Veronesi, Beatrice Bianchi, Elisa Bottazzoli, Valentina Tagliaferri, Erica Mazzotta, Giulia Castelnovo, Giulia Deguidi, Elisabetta Maria Cristina Rossi, Giovanni Corso
Cancers, 2022
A Randomized Trial of Robotic Mastectomy Versus Open Surgery in Women With Breast Cancer or BrCA Mutation
Antonio Toesca, Claudia Sangalli, Patrick Maisonneuve, Giulia Massari, Antonia Girardi, Jennifer L. Baker, Germana Lissidini, Alessandra Invento, Gabriel Farante, Giovanni Corso, Mario Rietjens, Nickolas Peradze, Alessandra Gottardi, Francesca Magnoni, Luca Bottiglieri, Matteo Lazzeroni, Emilia Montagna, Piergiorgio Labo, Roberto Orecchia, Viviana Galimberti, Mattia Intra, Virgilio Sacchini, Paolo Veronesi
Annals of Surgery, 2022
Pleiotropic cancer manifestations of germline CDH1 mutations: Risks and management
Giovanni Corso
Journal of Surgical Oncology, 2022
CDH1 germline mutations in families with hereditary lobular breast cancer
Antonia Girardi, Francesca Magnoni, Elisa Vicini, Andriana Kouloura, Carlo La Vecchia, Paolo Veronesi, Giovanni Corso
European Journal of Cancer Prevention, 2022
Global distribution of prophylactic total gastrectomy in E-cadherin (CDH1) mutations
Giovanni Corso, Francesca Magnoni, Vincenzo Nicastro, Vincenzo Bagnardi, Cristina Maria Trovato, Paolo Veronesi
Seminars in Oncology, 2022
CDH1 germline mutations in healthy individuals from families with the hereditary diffuse gastric cancer syndrome
Giovanni Corso, Francesca Magnoni, Giulia Massari, Cristina Maria Trovato, Alessandra Margherita De Scalzi, Elisa Vicini, Bernardo Bonanni, Paolo Veronesi, Viviana Galimberti, Vincenzo Bagnardi
Journal of Medical Genetics, 2022
Does failed mapping predict sentinel lymph node metastasis in cN0 breast cancer?
Francesca Magnoni, Giovanni Corso, Laura Gilardi, Eleonora Pagan, Giulia Massari, Antonia Girardi, Federico Ghidinelli, Vincenzo Bagnardi, Viviana Galimberti, Chiara Maria Grana, Paolo Veronesi
Future Oncology, 2022
Oncoplastic Breast-Conserving Surgery for Synchronous Multicentric and Multifocal Tumors: Is It Oncologically Safe? A Retrospective Matched-Cohort Analysis
Francesca De Lorenzi, Francesco Borelli, Eleonora Pagan, Vincenzo Bagnardi, Nickolas Peradze, Barbara Alicia Jereczek-Fossa, Cristina Leonardi, Giovanni Mazzarol, Giorgio Favia, Giovanni Corso, Emilia Montagna, Mario Rietjens, Paolo Veronesi
Annals of Surgical Oncology, 2022
Second Reply to: “Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which is the Worst?”
Giovanni Corso
Annals of Surgical Oncology, 2021
Ten-year outcome results of cT4 breast cancer after neoadjuvant treatment
Giovanni Corso, Sabrina Kahler‐Ribeiro‐Fontana, Eleonora Pagan, Vincenzo Bagnardi, Francesca Magnoni, Elisabetta Munzone, Luca Bottiglieri, Paolo Veronesi, Viviana Galimberti
Journal of Surgical Oncology, 2021
Breast cancer surgery: New issues
Francesca Magnoni, Sofia Alessandrini, Luca Alberti, Andrea Polizzi, Anna Rotili, Paolo Veronesi, Giovanni Corso
Current Oncology, 2021
Economic implications of ACOSOG Z0011 trial application into clinical practice at the European Institute of Oncology
Denise Mattar, Antonio Di Filippo, Alessandra Invento, Davide Radice, Marius Burcuta, Vincenzo Bagnardi, Francesca Magnoni, Giorgia Santomauro, Giovanni Corso, Giovanni Mazzarol, Giuseppe Viale, Virgilio Sacchini, Viviana Galimberti, Paolo Veronesi, Mattia Intra
European Journal of Surgical Oncology, 2021
Biological and clinical features of triple negative Invasive Lobular Carcinomas of the breast. Clinical outcome and actionable molecular alterations
Fabio Conforti, Laura Pala, Eleonora Pagan, Elena Guerini Rocco, Vincenzo Bagnardi, Emilia Montagna, Giulia Peruzzotti, Tommaso De Pas, Caterina Fumagalli, Silvana Pileggi, Chiara Pesenti, Sergio Marchini, Giovanni Corso, Caterina Marchio’, Anna Sapino, Rossella Graffeo, Laetitia Collet, Philippe Aftimos, Christos Sotiriou, Martine Piccart, Richard D. Gelber, Giuseppe Viale, Marco Colleoni, Aron Goldhirsch
Breast, 2021
Metaplastic Breast Carcinoma and Other Triple-Negative Subtype Breast Cancers: Which Is Worst?
Giovanni Corso
Annals of Surgical Oncology, 2021
Impact of radiation and hormonal therapy on the locoregional recurrence of elderly breast cancer: Are these necessary after breast-conserving surgery?
Giovanni Corso, Patrick Maisonneuve, Paolo Veronesi
Cancer, 2021
Hereditary breast cancer: Translation into clinical practice of recent American Society of Clinical Oncology, American Society of Radiation Oncology, and Society of Surgical Oncology recommendations
Giovanni Corso, Francesca Magnoni
European Journal of Cancer Prevention, 2021
Long-term outcome and axillary recurrence in elderly women (≥70 years) with breast cancer: 10-years follow-up from a matched cohort study
Giovanni Corso, Francesca Magnoni, Giacomo Montagna, Patrick Maisonneuve, Andrea Polizzi, Giulia Massari, Alessandra Invento, Antonia Girardi, Alessandra Margherita De Scalzi, Paolo Veronesi
European Journal of Surgical Oncology, 2021
Is Nipple-Sparing Mastectomy Indicated after Previous Breast Surgery? A Series of 387 Institutional Cases
Elisa Vicini, Francesca De Lorenzi, Alessandra Invento, Giovanni Corso, Davide Radice, Samantha Bozzo, Sabrina Kahler Ribeiro Fontana, Pietro Caldarella, Paolo Veronesi, Viviana Galimberti
Plastic and Reconstructive Surgery, 2021
Mastectomy alone for pT1-2 pN0-1 breast cancer patients: when postmastectomy radiotherapy is indicated
Maria Cristina Leonardi, Ida Rosalia Scognamiglio, Patrick Maisonneuve, Samantha Dicuonzo, Damaris Patricia Rojas, Maria Alessia Zerella, Anna Morra, Marianna Alessandra Gerardi, Mattia Zaffaroni, Alessandra De Scalzi, Antonia Girardi, Francesca Magnoni, Emilia Montagna, Cristiana Iuliana Fodor, Viviana Enrica Galimberti, Paolo Veronesi, Roberto Orecchia, Roberto Pacelli, Barbara Alicja Jereczek-Fossa, Giovanni Corso
Breast Cancer Research and Treatment, 2021
Frequency of cdh1 germline mutations in non-gastric cancers
Giulia Massari, Francesca Magnoni, Giorgio Favia, Nickolas Peradze, Paolo Veronesi, Carlo La Vecchia, Giovanni Corso
Cancers, 2021
Long-term standard sentinel node biopsy after neoadjuvant treatment in breast cancer: a single institution ten-year follow-up
Sabrina Kahler-Ribeiro-Fontana, Eleonora Pagan, Francesca Magnoni, Elisa Vicini, Consuelo Morigi, Giovanni Corso, Mattia Intra, Fiorella Canegallo, Silvia Ratini, Maria Cristina Leonardi, Eliana La Rocca, Vincenzo Bagnardi, Emilia Montagna, Marco Colleoni, Giuseppe Viale, Luca Bottiglieri, Chiara Maria Grana, Jorge Villanova Biasuz, Paolo Veronesi, Viviana Galimberti
European Journal of Surgical Oncology, 2021
Geographical distribution of e‐cadherin germline mutations in the context of diffuse gastric cancer: A systematic review
Giovanni Corso, Federica Corso, Federica Bellerba, Patrícia Carneiro, Susana Seixas, Antonio Cioffi, Carlo La Vecchia, Francesca Magnoni, Bernardo Bonanni, Paolo Veronesi, Sara Gandini, Joana Figueiredo
Cancers, 2021
Redefinition of familial intestinal gastric cancer: Clinical and genetic perspectives
Joana Carvalho, Patricia Oliveira, Janine Senz, Celina São José, Samantha Hansford, Sara Pinto Teles, Marta Ferreira, Giovanni Corso, Hugo Pinheiro, Diana Lemos, Valeria Pascale, Franco Roviello, David Huntsman, Carla Oliveira
Journal of Medical Genetics, 2021
Metaplastic breast cancer: Prognostic and therapeutic considerations
Giovanni Corso, Samuele Frassoni, Antonia Girardi, Elisa De Camilli, Emilia Montagna, Mattia Intra, Luca Bottiglieri, Alessandra Margherita De Scalzi, Denise Mattar Fanianos, Francesca Magnoni, Alessandra Invento, Antonio Toesca, Fabio Conforti, Vincenzo Bagnardi, Giuseppe Viale, Marco Angelo Colleoni, Paolo Veronesi
Journal of Surgical Oncology, 2021
Axillary surgery in breast cancer: Evolution and de-escalation
Paolo Veronesi, Federico Ghidinelli, Giovanni Corso
Minerva Chirurgica, 2020
Axillary management after neoadjuvant treatment
Giacomo Montagna, Giovanni Corso, Rosa Di Micco, Nathalie Van Den Rul, Nicola Rocco
Minerva Chirurgica, 2020
Axillary surgery in breast cancer: An updated historical perspective
Francesca Magnoni, Viviana Galimberti, Giovanni Corso, Mattia Intra, Virgilio Sacchini, Paolo Veronesi
Seminars in Oncology, 2020
Letter Regarding: Is Prophylactic Total Gastrectomy Always Indicated in CDH1 Germline Mutant Carriers?
Giovanni Corso
Journal of Surgical Research, 2020
E-cadherin (Cdh1 gene) germline mutations in gastric cancer: Evolutions and innovations
Giovanni Corso, Bernardo Bonanni
Cancers, 2020
How Useful Are Tumor Markers in Detecting Metastases with FDG-PET/CT during Breast Cancer Surveillance?
Giovanni Corso, Laura Gilardi, Antonia Girardi, Alessandra Margherita De Scalzi, Gianmatteo Pagani, Elisabetta Maria Cristina Rossi, Giacomo Montagna, Paolo Veronesi, Eleonora Pagan, Vincenzo Bagnardi, Chiara Maria Grana
Oncology Switzerland, 2020
Contralateral Axillary Lymph Node Metastases from Breast Carcinoma: Is it Time to Review TNM Cancer Staging?
Francesca Magnoni, M. Colleoni, D. Mattar, G. Corso, V. Bagnardi, S. Frassoni, G. Santomauro, B. A. Jereczek-Fossa, P. Veronesi, V. Galimberti, V. Sacchini, M. Intra
Annals of Surgical Oncology, 2020
Impact of COVID-19 pandemic on clinical and surgical breast cancer management
Paolo Veronesi, Giovanni Corso
Eclinicalmedicine, 2020
ASO Author Reflections: Clinical Implication of Nomograms in the Breast Oncology Field
Giovanni Corso
Annals of Surgical Oncology, 2020
Immediate breast reconstruction with latissimus dorsi flap for patients with local recurrence of breast cancer
F. De Lorenzi, G. Corso, F. Botta, A. Invento, A. Marchetti, P. Sala, G. Vottero, V. Bagnardi, C. Leonardi, P. Veronesi, A. Goldhirsch
European Journal of Surgical Oncology, 2020
Validation of a Novel Nomogram for Prediction of Local Relapse after Surgery for Invasive Breast Carcinoma
Giovanni Corso, Patrick Maisonneuve, Giulia Massari, Alessandra Invento, Gabriella Pravettoni, Alessandra De Scalzi, Mattia Intra, Viviana Galimberti, Consuelo Morigi, Milena Lauretta, Virgilio Sacchini, Paolo Veronesi
Annals of Surgical Oncology, 2020
E-cadherin deregulation in breast cancer
Giovanni Corso, Joana Figueiredo, Simone Pietro De Angelis, Federica Corso, Antonia Girardi, Joana Pereira, Raquel Seruca, Bernardo Bonanni, Patricia Carneiro, Gabriella Pravettoni, Elena Guerini Rocco, Paolo Veronesi, Giacomo Montagna, Virgilio Sacchini, Sara Gandini
Journal of Cellular and Molecular Medicine, 2020
Hereditary gastric and breast cancer syndromes related to CDH1 germline mutation: A multidisciplinary clinical review
Giovanni Corso, Giacomo Montagna, Joana Figueiredo, Carlo La Vecchia, Uberto Fumagalli Romario, Maria Sofia Fernandes, Susana Seixas, Franco Roviello, Cristina Trovato, Elena Guerini-Rocco, Nicola Fusco, Gabriella Pravettoni, Serena Petrocchi, Anna Rotili, Giulia Massari, Francesca Magnoni, Francesca De Lorenzi, Manuela Bottoni, Viviana Galimberti, João Miguel Sanches, Mariarosaria Calvello, Raquel Seruca, Bernardo Bonanni
Cancers, 2020
Germline mutations of the E-cadherin gene (CDH1) in early onset gastric cancer
Giovanni Corso, Franco Roviello
Seminars in Oncology, 2020
Implementation of the BRESO Theoretical and practical knowledge curriculum for European Breast Surgeons: The time has come
G. Montagna, J. Morgan, W. Wandschneider, A. Vinci, A. Esgueva, G. Corso, R. Di Micco, V. Vural, N. Rocco
European Journal of Surgical Oncology, 2020
De-escalation treatment of axilla in breast cancer
G. Corso, V. Galimberti, P. Veronesi
Clinical and Translational Oncology, 2020
Multicentric breast cancer with heterogeneous histopathology: A multidisciplinary review
Giovanni Corso, Francesca Magnoni, Elena Provenzano, Antonia Girardi, Monica Iorfida, Alessandra Margherita De Scalzi, Alessandra Invento, Marco Colleoni, Enrico Cassano, Chiara Trentin, Roberto Lo Gullo, Gabriella Pravettoni, Laura Gilardi, Chiara Maria Grana, Mattia Intra, Viviana Galimberti, Paolo Veronesi, Francesca De Lorenzi, Maria Cristina Leonardi
Future Oncology, 2020
Standard and controversies in sentinel node in breast cancer patients
P. Veronesi, G. Corso
Breast, 2019
Preventing physician distress: Burnout syndrome, a sneaky disease
Giovanni Corso, Paolo Veronesi, Gabriella Pravettoni
European Journal of Cancer Prevention, 2019
Familial lobular breast cancer: Is testing for germline CDH1 mutations necessary?
Giovanni Corso, Virgilio Sacchini, Gabriella Pravettoni, Paolo Veronesi, Bernardo Bonanni
European Journal of Surgical Oncology, 2019
Update on the Feasibility and Progress on Robotic Breast Surgery
Antonio Toesca, Alessandra Invento, Giulia Massari, Antonia Girardi, Nickolas Peradze, Germana Lissidini, Claudia Sangalli, Patrick Maisonneuve, Andrea Manconi, Alessandra Gottardi, Jennifer L. Baker, Luca Bottiglieri, Paola Naninato, Gabriel Farante, Francesca Magnoni, Alessandra De Scalzi, Giovanni Corso, Marco Colleoni, Francesca De Lorenzi, Virgilio Sacchini, Viviana Galimberti, Mattia Intra, Mario Rietjens, Paolo Veronesi
Annals of Surgical Oncology, 2019
Breast cancer with rare metastatic manifestation
Francesca Magnoni, Clementina Di Tonno, Giuseppe Accardo, Mariarosaria Calvello, Giovanni Corso, Virgilio Sacchini, Viviana Galimberti, Paolo Veronesi
Future Oncology, 2019
E-cadherin germline mutations in Māori population
Alessandra Margherita De Scalzi, Bernardo Bonanni, Viviana Galimberti, Paolo Veronesi, Gabriella Pravettoni, Giovanni Corso
Future Oncology, 2019
Clinical implication of E-cadherin deficiency in lobular breast cancer
Giovanni Corso, Gabriella Pravettoni, Viviana Galimberti, Paolo Veronesi
Breast Cancer Research and Treatment, 2019
Could radiotherapy play a major role in misidentification of sentinel lymph node in breast cancer recurrence?
Germana Lissidini, Giuseppe Trifirò, Paolo Veronesi, Chiara Grana, Stefano Zurrida, Viviana Galimberti, Giovanni Corso, Cecilia Vellani, Giovanni B. Ivaldi
Radiotherapy and Oncology, 2019
Nipple-sparing mastectomy with different approaches: surgical incisions, complications, and cosmetic results. Preliminary results of 100 consecutive patients at a single center
G. Corso, F. De Lorenzi, E. Vicini, G. Pagani, P. Veronesi, M. Sargenti, F. Magnoni, P. Naninato, P. Maisonneuve, C. Sangalli, M. Rietjens, Viviana Galimberti
Journal of Plastic Reconstructive and Aesthetic Surgery, 2018
Oncological Outcomes of Nipple-Sparing Mastectomy: A Single-Center Experience of 1989 Patients
Viviana Galimberti, Consuelo Morigi, Vincenzo Bagnardi, Giovanni Corso, Elisa Vicini, Sabrina Kahler Ribeiro Fontana, Paola Naninato, Silvia Ratini, Francesca Magnoni, Antonio Toesca, Andriana Kouloura, Mario Rietjens, Francesca De Lorenzi, Andrea Vingiani, Paolo Veronesi
Annals of Surgical Oncology, 2018
Corrigendum to “HPV infection and breast cancer. Results of a microarray approach” [The Breast 40, (August 2018) 165–169](S0960977618301024)(10.1016/j.breast.2018.05.010)
Andriana Kouloura, Electra Nicolaidou, Ioannis Misitzis, Euaggelia Panotopoulou, Kassiani Theodoraki, Vasilios Smyrniotis, Giovanni Corso, Paolo Veronesi, Nikolaos Arkadopoulos
Breast, 2018
Dosimetric study to assess the feasibility of intraoperative radiotherapy with electrons (ELIOT) as partial breast irradiation for patients with cardiac implantable electronic device (CIED)
Rosa Luraschi, Roberta Lazzari, Viviana Galimberti, Elena Rondi, Alessia Bazani, Giovanni Corso, Nicola Colombo, Rosalinda Ricotti, Cristiana Fodor, Mikolaj Winnicki, Maria Cristina Leonardi, Barbara Alicja Jereczek-Fossa, Federica Cattani
Breast Cancer Research and Treatment, 2018
Granular cell tumor of the breast: Molecular pathology and clinical management
Giovanni Corso, Brunella Di Nubila, Angelo Ciccia, Elisa De Camilli, Elisa Vicini, Chiara Trentin, Germana Lissidini, Linda Cairns, Paolo Veronesi, Viviana Galimberti
Breast Journal, 2018
HPV infection and breast cancer. Results of a microarray approach
Andriana Kouloura, Electra Nicolaidou, Ioannis Misitzis, Euaggelia Panotopoulou, Theodoraki Kassiani, Vasilios Smyrniotis, Giovanni Corso, Paolo Veronesi, Nikolaos Arkadopoulos
Breast, 2018
Ipsilateral Breast Tumor Reappearance and Contralateral Breast Cancer after Primary Breast Cancer Treatment: A Comprehensive Retrospective Study of 15,168 Patients
Giovanni Corso, Patrick Maisonneuve, Giorgia Irene Santomauro, Alessandra Margherita De Scalzi, Antonio Toesca, Fabio Domenico Bassi, Gabriel Farante, Pietro Caldarella, Mattia Intra, Viviana Galimberti, Paolo Veronesi
Oncology Switzerland, 2018
Oncoplastic breast surgery for the management of ductal carcinoma in situ (DCIS): is it oncologically safe? A retrospective cohort analysis
Francesca De Lorenzi, Julien Di Bella, Patrick Maisonneuve, Nicole Rotmensz, Giovanni Corso, Roberto Orecchia, Marco Colleoni, Giovanni Mazzarol, Mario Rietjens, Pietro Loschi, Stefano Marcelli, Paolo Veronesi, Viviana Galimberti
European Journal of Surgical Oncology, 2018
Hereditary lobular breast cancer with an emphasis on E-cadherin genetic defect
Giovanni Corso, Joana Figueiredo, Carlo La Vecchia, Paolo Veronesi, Gabriella Pravettoni, Debora Macis, Rachid Karam, Roberto Lo Gullo, Elena Provenzano, Antonio Toesca, Ketti Mazzocco, Fátima Carneiro, Raquel Seruca, Soraia Melo, Fernando Schmitt, Franco Roviello, Alessandra Margherita De Scalzi, Mattia Intra, Irene Feroce, Elisa De Camilli, Maria Grazia Villardita, Chiara Trentin, Francesca De Lorenzi, Bernardo Bonanni, Viviana Galimberti
Journal of Medical Genetics, 2018
Sentinel lymph node biopsy management after neoadjuvant treatment for breast cancer care
Giovanni Corso, Alessandra Margherita De Scalzi, Elisa Vicini, Consuelo Morigi, Paolo Veronesi, Viviana Galimberti
Future Oncology, 2018
Intra-operative radiotherapy management for breast cancer treatment in patients with pseudoxanthoma elasticum: A case report
Carmela Salerno, Anna Rita Vento, Maria Giacchino, Germana Lissidini, Viviana Galimberti, Giovanni Corso
Breast Journal, 2018
Multiple primary non-breast tumors in breast cancer survivors
Giovanni Corso, Paolo Veronesi, Giorgia Irene Santomauro, Patrick Maisonneuve, Consuelo Morigi, Giulia Peruzzotti, Mattia Intra, Virgilio Sacchini, Viviana Galimberti
Journal of Cancer Research and Clinical Oncology, 2018
Mutual exclusion of CDH1 and BRCA germline mutations in the pathway of hereditary breast cancer
G. Corso, B. Bonanni, P. Veronesi, V. Galimberti
Archives of Gynecology and Obstetrics, 2018
Prognosis and outcome in CDH1-mutant lobular breast cancer
Giovanni Corso, Paolo Veronesi, Virgilio Sacchini, Viviana Galimberti
European Journal of Cancer Prevention, 2018
The Italian Ministry of Health promotes more than 300 research projects to improve cancer prevention, treatment, and prognosis
Giovanni Corso, Debora Macis, Paolo Veronesi, Bernardo Bonanni, Viviana Galimberti
European Journal of Cancer Prevention, 2018
Clinical criteria revision for hereditary lobular breast cancer associated with E-cadherin germline mutations
Giovanni Corso, Alessandra De Scalzi, Irene Feroce, Paolo Veronesi, Bernardo Bonanni, Viviana Galimberti
Personalized Medicine, 2018
BRCA1/2 germline missense mutations: A systematic review
Giovanni Corso, Irene Feroce, Mattia Intra, Antonio Toesca, Francesca Magnoni, Manuela Sargenti, Paola Naninato, Pietro Caldarella, Gianmatteo Pagani, Annarita Vento, Paolo Veronesi, Bernardo Bonanni, Viviana Galimberti
European Journal of Cancer Prevention, 2018
Axillary blue sentinel lymph node: an unusual tattoo?
Giovanni Corso, Denise Mattar Fanianos, Viviana Galimberti, Mattia Intra
European Journal of Nuclear Medicine and Molecular Imaging, 2017
Prognostic impact of germline mutations in inherited cancer syndromes
Giovanni Corso, Irene Feroce, Mattia Intra, Paolo Veronesi, Virgilio Sacchini, Bernardo Bonanni, Viviana Galimberti
Future Oncology, 2017
Nipple-sparing and skin-sparing mastectomy: Review of aims, oncological safety and contraindications
Viviana Galimberti, Elisa Vicini, Giovanni Corso, Consuelo Morigi, Sabrina Fontana, Virgilio Sacchini, Paolo Veronesi
Breast, 2017
PIK3CA oncogenic mutations in neoadjuvant treatments for breast cancer
Giovanni Corso, Paolo Veronesi, Mattia Intra, Virgilio Sacchini, Viviana Galimberti
Biomarkers in Medicine, 2017
The Veronesi quadrantectomy: An historical overview
Giovanni Corso, Paolo Veronesi, Virgilio Sacchini, Viviana Galimberti, Alberto Luini
Ecancermedicalscience, 2017
Feasibility of lymphoscintigraphy for sentinel node identification after neo-adjuvant therapy
Annali Italiani Di Chirurgia, 2017
Somatic copy number alterations in gastric adenocarcinomas among Asian and Western patients
Steven E. Schumacher, Byoung Yong Shim, Giovanni Corso, Min-Hee Ryu, Yoon-Koo Kang, Franco Roviello, Gordon Saksena, Shouyong Peng, Ramesh A. Shivdasani, Adam J. Bass, Rameen Beroukhim
Plos One, 2017
Supernumerary Axillary Breast Cancer
Santos Soto, Antonio Toesca, Alaa Hamza, Gianni Antonio Della Corte, Marco Iera, Nickolas Peradze, Nicola Rocco, Galimberti Viviana Enrica, Bernardo Bonanni, Giovanni Corso, Alberto Luini, Mario Rietjens, Francesca De Lorenzi, Paolo Veronesi, Stefano Martella
Breast Journal, 2017
Overexploring and overtreating the axilla
Viviana Galimberti, Giovanni Corso, Simonetta Monti, Gianmatteo Pagani
Breast, 2017
Surgical resection margins after breast-conserving surgery: Senonetwork recommendations
Viviana Galimberti, Mario Taffurelli, Maria Cristina Leonardi, Cynthia Aristei, Chiara Trentin, Enrico Cassano, Francesca Pietribiasi, Giovanni Corso, Elisabetta Munzone, Carlo Tondini, Alfonso Frigerio, Luigi Cataliotti, Donatella Santini
Tumori, 2016
CDH1 germline mutations and hereditary lobular breast cancer
Giovanni Corso, Mattia Intra, Chiara Trentin, Paolo Veronesi, Viviana Galimberti
Familial Cancer, 2016
Assessment of a tumor bank: a thirty years experience of the University of Siena (Italy)
G. Corso, L. Garosi, D. Marrelli, F. Roviello
Cell and Tissue Banking, 2015
Hereditary diffuse gastric cancer syndrome: CDH1 mutations and beyond
Samantha Hansford, Pardeep Kaurah, Hector Li-Chang, Michelle Woo, Janine Senz, Hugo Pinheiro, Kasmintan A. Schrader, David F. Schaeffer, Karey Shumansky, George Zogopoulos, Teresa Almeida Santos, Isabel Claro, Joana Carvalho, Cydney Nielsen, Sarah Padilla, Amy Lum, Aline Talhouk, Katie Baker-Lange, Sue Richardson, Ivy Lewis, Noralane M. Lindor, Erin Pennell, Andree MacMillan, Bridget Fernandez, Gisella Keller, Henry Lynch, Sohrab P. Shah, Parry Guilford, Steven Gallinger, Giovanni Corso, Franco Roviello, Carlos Caldas, Carla Oliveira, Paul D. P. Pharoah, David G. Huntsman
JAMA Oncology, 2015
E-cadherin germline mutation carriers: clinical management and genetic implications
Giovanni Corso, Joana Figueiredo, Roberto Biffi, Chiara Trentin, Bernardo Bonanni, Irene Feroce, Davide Serrano, Enrico Cassano, Bruno Annibale, Soraia Melo, Raquel Seruca, Francesca De Lorenzi, Francesco Ferrara, Riccardo Piagnerelli, Franco Roviello, Viviana Galimberti
Cancer and Metastasis Reviews, 2014
Long-term follow-up of 5262 breast cancer patients with negative sentinel node and no axillary dissection confirms low rate of axillary disease
V. Galimberti, A. Manika, P. Maisonneuve, G. Corso, L. Salazar Moltrasio, M. Intra, O. Gentilini, P. Veronesi, G. Pagani, E. Rossi, L. Bottiglieri, G. Viale, N. Rotmensz, C. De Cicco, C.M. Grana, C. Sangalli, A. Luini
European Journal of Surgical Oncology, 2014
Oncogenic mutations and microsatellite instability phenotype predict specific anatomical subsite in colorectal cancer patients
Giovanni Corso, Valeria Pascale, Giuseppe Flauti, Francesco Ferrara, Daniele Marrelli, Franco Roviello
European Journal of Human Genetics, 2013
Gastro-pleuro-pericardial fistula following combined radiation and chemotherapy for lung metastases from renal cell carcinoma: Report of a case
Alessandro Neri, Youdel Lambert, Daniele Marrelli, Giulio Di Mare, Doralba Mastrogiacomo, Giovanni Corso, Luca Volterrani, Franco Roviello
Surgery Today, 2013
Standard and extended lymphadenectomy: Technical notes
Franco Roviello, Giovanni Corso, Daniele Marrelli
Surgery in the Multimodal Management of Gastric Cancer, 2013
History, pathogenesis, and management of familial gastric cancer: Original study of john XXIII's family
Giovanni Corso, Fabrizio Roncalli, Daniele Marrelli, Fátima Carneiro, Franco Roviello
Biomed Research International, 2013
Somatic mutations and deletions of the e-cadherin gene predict poor survival of patients with gastric cancer
Giovanni Corso, Joana Carvalho, Daniele Marrelli, Carla Vindigni, Beatriz Carvalho, Raquel Seruca, Franco Roviello, Carla Oliveira
Journal of Clinical Oncology, 2013
Historical overview of familial gastric cancer
Giovanni Corso
Spotlight on Familial and Hereditary Gastric Cancer, 2013
Gastric cancer in other inherited syndromes
Giovanni Corso, Sérgia Velho
Spotlight on Familial and Hereditary Gastric Cancer, 2013
Spotlight on familial and hereditary gastric cancer
Giovanni Corso, Franco Roviello
Spotlight on Familial and Hereditary Gastric Cancer, 2013
Frequency of familial gastric cancer
Giovanni Corso, Daniele Marrelli
Spotlight on Familial and Hereditary Gastric Cancer, 2013
Clinical management of familial gastric cancer
Giovanni Corso, Daniele Marrelli, Franco Roviello
Spotlight on Familial and Hereditary Gastric Cancer, 2013
The family cancer database
Giovanni Corso, Daniele Marrelli, Franco Roviello
Spotlight on Familial and Hereditary Gastric Cancer, 2013
Prophylactic total gastrectomy in CDH1 germline mutation carriers
Francesco Ferrara, Giovanni Corso, Franco Roviello
Spotlight on Familial and Hereditary Gastric Cancer, 2013
Non- CDH1 -associated familial gastric cancer and epigenetics factors
Marina Leite, Giovanni Corso, Sónia Sousa, Joana Carvalho, Franco Roviello, Carla Oliveira, Ceu Figueiredo, Raquel Seruca
Spotlight on Familial and Hereditary Gastric Cancer, 2013
Etiopathogenesis of Gastric Cancer
Giovanni Corso, Daniele Marrelli, Franco Roviello
Surgery in the Multimodal Management of Gastric Cancer, 2012
Long-term results after R0 resection in the surgical treatment of gastric cancer
Franco Roviello, Giovanni Corso, Daniele Marrelli
Surgery in the Multimodal Management of Gastric Cancer, 2012
Gastrointestinal adenocarcinomas of the esophagus, stomach, and colon exhibit distinct patterns of genome instability and oncogenesis
Austin M. Dulak, Steven E. Schumacher, Jasper van Lieshout, Yu Imamura, Cameron Fox, Byoungyong Shim, Alex H. Ramos, Gordon Saksena, Sylvan C. Baca, Jose Baselga, Josep Tabernero, Jordi Barretina, Peter C. Enzinger, Giovanni Corso, Franco Roviello, Lin Lin, Santhoshi Bandla, James D. Luketich, Arjun Pennathur, Matthew Meyerson, Shuji Ogino, Ramesh A. Shivdasani, David G. Beer, Tony E. Godfrey, Rameen Beroukhim, Adam J. Bass
Cancer Research, 2012
CPEB1, a novel gene silenced in gastric cancer: A Drosophila approach
Joana Caldeira, Joana Simões-Correia, Joana Paredes, Marta T Pinto, Sónia Sousa, Giovanni Corso, Daniele Marrelli, Franco Roviello, Paulo S Pereira, Dominique Weil, Carla Oliveira, Fernando Casares, Raquel Seruca
Gut, 2012
Ultraviolet radiation resistance-associated polyadenine deletions in human gastric cancer
Giovanni Corso, Valeria Pascale, Daniele Marrelli, Franco Roviello
Human Pathology, 2012
Frequency of CDH1 germline mutations in gastric carcinoma coming from high- and low-risk areas: Metanalysis and systematic review of the literature
Giovanni Corso, Daniele Marrelli, Valeria Pascale, Carla Vindigni, Franco Roviello
BMC Cancer, 2012
Familial gastric cancer and germline mutations of E-cadherin
Annali Italiani Di Chirurgia, 2012
Gastric cancer carcinogenesis and tumor progression
Annali Italiani Di Chirurgia, 2012
High accuracy of multislices computed tomography (MSCT) for para-aortic lymph node metastases from gastric cancer: A prospective single-center study
Daniele Marrelli, Maria Antonietta Mazzei, Corrado Pedrazzani, Marianna Di Martino, Carla Vindigni, Giovanni Corso, Eleonora Morelli, Luca Volterrani, Franco Roviello
Annals of Surgical Oncology, 2011
Familial gastric cancer: Update for practice management
Giovanni Corso, Daniele Marrelli, Franco Roviello
Familial Cancer, 2011
Epigenetically silenced miR-34b/c as a novel faecal-based screening marker for colorectal cancer
M Kalimutho, S Di Cecilia, G Del Vecchio Blanco, F Roviello, P Sileri, M Cretella, A Formosa, G Corso, D Marrelli, F Pallone, G Federici, S Bernardini
British Journal of Cancer, 2011
MSI phenotype and MMR alterations in familial and sporadic gastric cancer
Marina Leite, Giovanni Corso, Sónia Sousa, Fernanda Milanezi, Luís P. Afonso, Rui Henrique, José Manuel Soares, Sérgio Castedo, Fátima Carneiro, Franco Roviello, Carla Oliveira, Raquel Seruca
International Journal of Cancer, 2011
E-cadherin genetic screening and clinico-pathologic characteristics of early onset gastric cancer
Giovanni Corso, Corrado Pedrazzani, Hugo Pinheiro, Eduardo Fernandes, Daniele Marrelli, Andrea Rinnovati, Valeria Pascale, Raquel Seruca, Carla Oliveira, Franco Roviello
European Journal of Cancer, 2011
Oncogenic mutations in gastric cancer with microsatellite instability
Giovanni Corso, Sérgia Velho, Joana Paredes, Corrado Pedrazzani, Diana Martins, Fernanda Milanezi, Valeria Pascale, Carla Vindigni, Hugo Pinheiro, Marina Leite, Daniele Marrelli, Sónia Sousa, Fátima Carneiro, Carla Oliveira, Franco Roviello, Raquel Seruca
European Journal of Cancer, 2011
Safety and potential benefit of hyperthermic intraperitoneal chemotherapy (HIPEC) in peritoneal carcinomatosis from primary or recurrent ovarian cancer
Franco Roviello, Enrico Pinto, Giovanni Corso, Corrado Pedrazzani, Stefano Caruso, Marco Filippeschi, Roberto Petrioli, Stefania Marsili, Maria Antonietta Mazzei, Daniele Marrelli
Journal of Surgical Oncology, 2010
Familial gastric cancer and Li-Fraumeni syndrome
G. CORSO, C. PEDRAZZANI, D. MARRELLI, E. PINTO, F. ROVIELLO
European Journal of Cancer Care, 2010
Super-extended (D3) lymphadenectomy in advanced gastric cancer
F. Roviello, C. Pedrazzani, D. Marrelli, A. Di Leo, S. Caruso, S. Giacopuzzi, G. Corso, G. de Manzoni
European Journal of Surgical Oncology, 2010
KRAS Signaling Pathway Alterations in Microsatellite Unstable Gastrointestinal Cancers
Sérgia Velho, Giovanni Corso, Carla Oliveíra, Raquel Seruca
Advances in Cancer Research, 2010
Ratio between metastatic and examined lymph nodes (N ratio) may have low clinical utility in gastric cancer patients treated by limited lymphadenectomy: Results from a single-center experience of 526 patients
Corrado Pedrazzani, Armands Sivins, Guntis Ancans, Daniele Marrelli, Giovanni Corso, Viesturs Krumins, Franco Roviello, Marcis Leja
World Journal of Surgery, 2010
Is circulating D-dimer level a better prognostic indicator than CEA in resectable colorectal cancer? Our experience on 199 cases
Corrado Pedrazzani, Guido Cerullo, Daniele Marrelli, Eduardo Fernandes, Filippo Carlucci, Giovanni Corso, Francesca Bettarini, Alfonso De Stefano, Franco Roviello
International Journal of Biological Markers, 2010
A rare case of primary small bowel adenocarcinoma with intussusception
Stefano Caruso, Daniele Marrelli, Corrado Pedrazzani, Alessandro Neri, Maria Antonietta Mazzei, Monica Onorati, Giovanni Corso, Guido Cerullo, Franco Roviello
Tumori, 2010
Gastric cardia carcinoma is associated with the promoter -77T>C gene polymorphism of X-Ray Cross-Complementing Group 1 (XRCC1)
Giovanni Corso, Daniele Marrelli, Corrado Pedrazzani, José Carlos Machado, Stefano Mancini, Raquel Seruca, Franco Roviello
Journal of Gastrointestinal Surgery, 2009
Profiling critical cancer gene mutations in clinical tumor samples
Laura E. MacConaill, Catarina D. Campbell, Sarah M. Kehoe, Adam J. Bass, Charles Hatton, Lili Niu, Matt Davis, Keluo Yao, Megan Hanna, Chandrani Mondal, Lauren Luongo, Caroline M. Emery, Alissa C. Baker, Juliet Philips, Deborah J. Goff, Michelangelo Fiorentino, Mark A. Rubin, Kornelia Polyak, Jennifer Chan, Yuexiang Wang, Jonathan A. Fletcher, Sandro Santagata, Gianni Corso, Franco Roviello, Ramesh Shivdasani, Mark W. Kieran, Keith L. Ligon, Charles D. Stiles, William C. Hahn, Matthew L. Meyerson, Levi A. Garraway
Plos One, 2009
Evidence of tumor microsatellite instability in gastric cancer with familial aggregation
Corrado Pedrazzani, Giovanni Corso, Sérgia Velho, Marina Leite, Valeria Pascale, Francesca Bettarini, Daniele Marrelli, Raquel Seruca, Franco Roviello
Familial Cancer, 2009
Correlation of microsatellite instability at multiple loci with long-term survival in advanced gastric carcinoma
Giovanni Corso
Archives of Surgery, 2009
Different pathological features and prognosis in gastric cancer patients coming from high-risk and low-risk areas of Italy
Daniele Marrelli, Corrado Pedrazzani, Giovanni Corso, Alessandro Neri, Marianna Di Martino, Enrico Pinto, Franco Roviello
Annals of Surgery, 2009
Negative Helicobacter pylori status is associated with poor prognosis in patients with gastric cancer
Daniele Marrelli, Corrado Pedrazzani, Anna Berardi, Giovanni Corso, Alessandro Neri, Lorenzo Garosi, Carla Vindigni, Annalisa Santucci, Natale Figura, Franco Roviello
Cancer, 2009
Germline CDH1 deletions in hereditary diffuse gastric cancer families
C. Oliveira, J. Senz, P. Kaurah, H. Pinheiro, R. Sanges, A. Haegert, G. Corso, J. Schouten, R. Fitzgerald, H. Vogelsang, G. Keller, S. Dwerryhouse, D. Grimmer, S.-F. Chin, H.-K. Yang, C. E. Jackson, R. Seruca, F. Roviello, E. Stupka, C. Caldas, D. Huntsman
Human Molecular Genetics, 2009
CDH1 C-160A promoter polymorphism and gastric cancer risk
Giovanni Corso, Anna Berardi, Daniele Marrelli, Corrado Pedrazzani, Lorenzo Garosi, Enrico Pinto, Franco Roviello
European Journal of Cancer Prevention, 2009
Prognostic relevance of proliferative activity evaluated by Mib-1 immunostaining in node negative breast cancer
A. Neri, D. Marrelli, C. Pedrazzani, S. Caruso, A. De Stefano, F. Mariani, T. Megha, G. De Marco, G. Corso, E. Pinto, F. Roviello
European Journal of Surgical Oncology, 2008
The interferon gamma receptor 1 (IFNGR1) -56C/T gene polymorphism is associated with increased risk of early gastric carcinoma
P Canedo, G Corso, F Pereira, N Lunet, G Suriano, C Figueiredo, C Pedrazzani, H Moreira, H Barros, F Carneiro, R Seruca, F Roviello, J C Machado
Gut, 2008
Influence of age on soluble E-cadherin serum levels prevents its utility as a disease marker in gastric cancer patients
Corrado Pedrazzani, Stefano Caruso, Giovanni Corso, Daniele Marrelli, Alessandro Neri, Anna Berardi, Franco Roviello
Scandinavian Journal of Gastroenterology, 2008
[Surgical treatment of gastric cancer].
Chirurgia Italiana, 2008
High incidence of familial gastric cancer in Tuscany, a region in Italy
Franco Roviello, Giovanni Corso, Corrado Pedrazzani, Daniele Marrelli, Giulia De Falco, Gianpaolo Suriano, Carla Vindigni, Anna Berardi, Lorenzo Garosi, Alfonso De Stefano, Lorenzo Leoncini, Raquel Seruca, Enrico Pinto
Oncology, 2008
E-cadherin and hereditary diffuse gastric cancer
Corrado Pedrazzani, Giovanni Corso, Daniele Marrelli, Franco Roviello
Surgery, 2007
Characterization of the P373L E-cadherin germline missense mutation and implication for clinical management
G. Corso, F. Roviello, J. Paredes, C. Pedrazzani, M. Novais, J. Correia, D. Marrelli, L. Cirnes, R. Seruca, C. Oliveira, G. Suriano
European Journal of Surgical Oncology, 2007
Lymph node involvement in advanced gastroesophageal junction adenocarcinoma
Corrado Pedrazzani, Giovanni de Manzoni, Daniele Marrelli, Simone Giacopuzzi, Giovanni Corso, Anna Maria Minicozzi, Bernardino Rampone, Franco Roviello
Journal of Thoracic and Cardiovascular Surgery, 2007
Postoperative complications and functional results after subtotal gastrectomy with Billroth II reconstruction for primary gastric cancer
Corrado Pedrazzani, Daniele Marrelli, Bernardino Rampone, Alfonso De Stefano, Giovanni Corso, Giuseppe Fotia, Enrico Pinto, Franco Roviello
Digestive Diseases and Sciences, 2007
Hereditary diffuse gastric cancer and E-cadherin: Description of the first germline mutation in an Italian family
F. Roviello, G. Corso, C. Pedrazzani, D. Marrelli, G. De Falco, A. Berardi, L. Garosi, G. Suriano, C. Vindigni, A. De Stefano, L. Leoncini, R. Seruca, E. Pinto
European Journal of Surgical Oncology, 2007
Nodal staging in adenocarcinoma of the gastro-esophageal junction. Proposal of a specific staging system
Corrado Pedrazzani, Giovanni de Manzoni, Daniele Marrelli, Simone Giacopuzzi, Giovanni Corso, Marco Bernini, Franco Roviello
Annals of Surgical Oncology, 2007
Complications after extended (D2) and superextended (D3) lymphadenectomy for gastric cancer: Analysis of potential risk factors
Daniele Marrelli, Corrado Pedrazzani, Alessandro Neri, Giovanni Corso, Alfonso De Stefano, Enrico Pinto, Franco Roviello
Annals of Surgical Oncology, 2007
Breast cancer local recurrence: Risk factors and prognostic relevance of early time to recurrence
A. Neri, D. Marrelli, S. Rossi, A. De Stefano, F. Mariani, G. De Marco, S. Caruso, G. Corso, T. Cioppa, E. Pinto, F. Roviello
World Journal of Surgery, 2007
Number of lymph node metastases and its prognostic significance in early gastric cancer: A multicenter Italian study
Franco Roviello, Simone Rossi, Daniele Marrelli, Corrado Pedrazzani, Giovanni Corso, Carla Vindigni, Paolo Morgagni, Luca Saragoni, Giovanni de Manzoni, Anna Tomezzoli
Journal of Surgical Oncology, 2006
Bcl-2 expression correlates with lymphovascular invasion and long-term prognosis in breast cancer
Alessandro Neri, Daniele Marrelli, Franco Roviello, Giovanni De Marco, Federico Mariani, Alfonso De Stefano, Tiziana Megha, Stefano Caruso, Gianni Corso, Tommaso Cioppa, Enrico Pinto
Breast Cancer Research and Treatment, 2006
Late recurrence of malignant melanoma presenting as small bowel intussusception
Bernardino Rampone, Franco Roviello, Daniele Marrelli, Giovanni De Marco, Simone Rossi, Giovanni Corso, Guido Cerullo, Enrico Pinto
Digestive Diseases and Sciences, 2006
Perforated gastric carcinoma: A report of 10 cases and review of the literature
Franco Roviello, Simone Rossi, Daniele Marrelli, Giovanni De Manzoni, Corrado Pedrazzani, Paolo Morgagni, Giovanni Corso, Enrico Pinto
World Journal of Surgical Oncology, 2006
Peritoneal carcinomatosis due to ocular melanoma [2]
Minerva Chirurgica, 2006
A clinical case of duodenal gastrointestinal stromal tumor with a peculiarity in the surgical approach
Giovanni De Marco, Franco Roviello, Daniele Marrelli, Alfonso De Stefano, Alessandro Neri, Simone Rossi, Giovanni Corso, Bernardino Rampone, Giacomo Nastri, Enrico Pinto
Tumori, 2005

Giovanni Corso

EDUCATION

RESEARCH, TEACHING, or OTHER INTERESTS

Scopus Publications

RECENT SCHOLAR PUBLICATIONS

MOST CITED SCHOLAR PUBLICATIONS